PLU
TEVA icon

Performa Ltd (US)’s Teva Pharmaceuticals TEVA Stock Holding History

Performa Ltd (US)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-400
Closed -$8.08K – 57
2025
Q3 		$8.08K Buy
400
+100
+33% +$1.76K ﹤0.01% 29
2025
Q2 		$5.03K Buy
+300
New +$4.84K ﹤0.01% 37
2024
Q3 		– Sell
-385
Closed -$6.26K – 57
2024
Q2 		$6.26K Sell
385
-200
-34% -$3.08K ﹤0.01% 39
2024
Q1 		$8.25K Hold
585
– – ﹤0.01% 37
2023
Q4 		$6.11K Hold
585
– – ﹤0.01% 40
2023
Q3 		$5.97K Hold
585
– – ﹤0.01% 49
2023
Q2 		$4.41K Hold
585
– – ﹤0.01% 61
2023
Q1 		$5.18K Hold
585
– – ﹤0.01% 56
2022
Q4 		$5.33K Hold
585
– – ﹤0.01% 53
2022
Q3 		$5K Sell
585
-215
-27% -$1.9K ﹤0.01% 51
2022
Q2 		$6K Buy
800
+50
+7% +$436 ﹤0.01% 38
2022
Q1 		$7K Sell
750
-300
-29% -$2.5K ﹤0.01% 28
2021
Q4 		$8K Buy
1,050
+650
+163% +$5.87K ﹤0.01% 32
2021
Q3 		$4K Buy
400
+300
+300% +$2.81K ﹤0.01% 37
2021
Q2 		$1K Hold
100
– – ﹤0.01% 47
2021
Q1 		$1K Sell
100
-50
-33% -$573 ﹤0.01% 37
2020
Q4 		$1K Buy
+150
New +$1.44K ﹤0.01% 36
2020
Q1 		– Sell
-15,000
Closed -$147K – 13
2019
Q4 		$147K Sell
15,000
-3,300
-18% -$29.5K 0.14% 7
2019
Q3 		$169K Hold
18,300
– – 0.17% 5
2019
Q2 		$169K Buy
+18,300
New +$221K 0.17% 5

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Performa Ltd (US)'s TEVA Position: Q4 2025 in Review

Performa Ltd (US) sold out of Teva Pharmaceuticals (TEVA) in Q4 2025, closing a stake of 400 shares — an estimated $8.08K sold.

Performa Ltd (US) first reported a position in TEVA in Q2 2019 and held it in 20 quarters. The position peaked at $169K in Q3 2019. 629 funds tracked by Wall St. Rank hold TEVA as of Q4 2025.

  • Performa Ltd (US) reported no remaining Teva Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Performa Ltd (US) sold 400 Teva Pharmaceuticals shares in Q4 2025, an estimated $8.08K.
  • Performa Ltd (US) first reported a position in Teva Pharmaceuticals in Q2 2019 and held it in 20 quarters.
  • Performa Ltd (US)'s Teva Pharmaceuticals position peaked at $169K in Q3 2019.
  • 629 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2025.

Based on Performa Ltd (US)'s 13F filing for Q4 2025, filed 10 Feb 2026.